News

European Medical Journal5h
WHO Backs Twice-Yearly Lenacapavir Injection for HIV Prevention
WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.
New Vision on MSN15h
WHO recommends Uganda-tested HIV prevention drug, issues guidelines on usage
The recommendation comes just weeks after the US Food and Drug Administration (FDA) approved the drug for use. Lenacapavir trials were conducted in Uganda and South Africa and demonstrated 100% ...
A New HIV Shield: One Shot Every Six Months – Could This Be The Turning Point The World’s Been Waiting For?
The WHO has approved the use of a new drug to prevent HIV. The drug is called Lenacapavir, and what makes it unique is that ...